The Prizma has sadly generated next to no interest.
Plenty of jurisdictions where it has approvals over a period and no sales.
Hygea and it’s health care network were going to order just under US$ 1 million’s worth a month on average. Instead they restructure and the order is now on hold.
Roadshows couldn’t produce sales.
If the medical market are jittery about the product, imagine how jittery they are about the company.
The Prizma has sadly generated next to no interest.Plenty of...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)